AptarGroup, Inc. (ATR)
- Previous Close
139.11 - Open
139.06 - Bid --
- Ask --
- Day's Range
138.77 - 139.92 - 52 Week Range
111.63 - 145.35 - Volume
220,567 - Avg. Volume
300,934 - Market Cap (intraday)
9.22B - Beta (5Y Monthly) 0.58
- PE Ratio (TTM)
32.71 - EPS (TTM)
4.26 - Earnings Date Apr 25, 2024
- Forward Dividend & Yield 1.64 (1.18%)
- Ex-Dividend Date Apr 24, 2024
- 1y Target Est
147.80
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, and aerosol valves to the digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
www.aptar.com13,800
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: ATR
Performance Overview: ATR
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ATR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ATR
Valuation Measures
Market Cap
9.22B
Enterprise Value
10.18B
Trailing P/E
32.79
Forward P/E
27.62
PEG Ratio (5yr expected)
3.31
Price/Sales (ttm)
2.67
Price/Book (mrq)
4.00
Enterprise Value/Revenue
2.92
Enterprise Value/EBITDA
15.34
Financial Highlights
Profitability and Income Statement
Profit Margin
8.16%
Return on Assets (ttm)
6.51%
Return on Equity (ttm)
12.95%
Revenue (ttm)
3.49B
Net Income Avi to Common (ttm)
284.49M
Diluted EPS (ttm)
4.26
Balance Sheet and Cash Flow
Total Cash (mrq)
223.64M
Total Debt/Equity (mrq)
52.60%
Levered Free Cash Flow (ttm)
179.2M
Research Analysis: ATR
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Research Reports: ATR
ATR: Lowering target price to $146.00
APTARGROUP INC has an Investment Rating of HOLD; a target price of $146.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingNeutralPrice TargetATR: Lowering target price to $147.00
APTARGROUP INC has an Investment Rating of HOLD; a target price of $147.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingNeutralPrice TargetATR: Lowering target price to $148.00
APTARGROUP INC has an Investment Rating of HOLD; a target price of $148.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingNeutralPrice TargetATR: Raising target price to $150.00
APTARGROUP INC has an Investment Rating of HOLD; a target price of $150.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingNeutralPrice Target